We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > OPHTHALMOLOGY

News List

Amarantus forms Elto Pharma for CNS Disorders and MANF Therapeutics for Ophthalmology europeanpharmaceuticalreview
April 19, 2017
Amarantus Bioscience has formed a wholly-owned subsidiary named Elto Pharma for the purpose of creating investment vehicles focused exclusively on the further development of Eltoprazine...
Amarantus Forms Subsidiaries "Elto Pharma" to Focus on CNS Disorders and "MANF Therapeutics" to Focu americanpharmaceuticalreview
April 18, 2017
Amarantus Bioscience Holdings, Inc. has announced it has formed a wholly-owned subsidiary named Elto Pharma, Inc. for the purpose of further development of Eltoprazine...
Santen and twoXAR to identify new drug candidates for glaucoma pharmaceutical-technology
February 28, 2017
US-based ophthalmology company Santen and biopharmaceutical company twoXAR have entered a strategic research collaboration to identify new drug candidates for glaucoma.

Previous page 1 2 Next page